椎間板変性疾患治療の世界市場レポート 2025年

椎間板変性疾患治療市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.9％で、378億6,000万米ドルに成長します。予測期間の成長は、ヘルスケア支出の増加、低侵襲手術に対する需要の高まり、患者教育の強化、臨床研究の拡大、脊椎疾患の世界の罹患率の上昇などに起因しています。予測期間における主な動向としては、AIと機械学習の統合、再生医療の開発、低侵襲手術の進歩、ウェアラブル技術、カスタムインプラント用3Dプリンティング、遠隔医療、遠隔診察、個別化医療の重視などが挙げられます。

スポーツ傷害の発生率の増加が、今後数年間の椎間板変性疾患治療市場の成長を促進すると予想されます。スポーツ傷害とは、アスリートや身体活動に携わる個人が受ける身体的損傷や外傷を指し、多くの場合、突然の衝撃や使い過ぎ、不適切な技術によって引き起こされます。スポーツ傷害の増加は、参加率の増加、より厳しいトレーニングルーチン、競合パフォーマンスへのより強い集中などの要因に関連することが多いです。椎間板変性疾患治療は、椎間板変性がアスリートのパフォーマンスや可動性に影響を及ぼす場合、慢性的な脊髄疼痛の管理や機能回復に活用されます。例えば、2023年11月、英国を拠点とする保険仲介会社Howden Group Holdings Ltdは、2022年10月の負傷により、大会前に選手が平均11.35日間欠場し、2023年1月には19.41日間に増加したと報告しました。したがって、スポーツ傷害の増加が椎間板変性疾患治療市場の拡大に拍車をかけています。

椎間板変性疾患治療市場の主要企業は、椎間板の容積を増やし、腰痛を緩和し、鎮痛剤への依存を減らすことで患者の予後を改善するため、注射可能椎間板細胞療法（IDCT）などの革新的な治療法の開発に注力しています。注射による椎間板細胞治療（IDCT）は、症候性の腰椎変性椎間板症のために考案された再生治療です。例えば、2023年2月、米国のバイオ医薬品会社DiscGenics Inc.は、症候性腰椎変性椎間板症を対象とする注射可能椎間板細胞療法（IDCT）について、FDAの再生医療先進医療指定を受けた。この最先端治療は、提供された成人のヒト椎間板組織由来の生きた前駆細胞集団を用います。IDCTは、椎間板の容積を増加させ、腰痛を緩和し、罹患患者の鎮痛剤の必要性を軽減することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界椎間板変性疾患治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の椎間板変性疾患治療市場：成長率分析
• 世界の椎間板変性疾患治療市場の実績：規模と成長, 2019-2024
• 世界の椎間板変性疾患治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界椎間板変性疾患治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の椎間板変性疾患治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 従来の薬
• 新しい治療法
• 世界の椎間板変性疾患治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 注射剤
• 世界の椎間板変性疾患治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• 整形外科センター
• 世界の椎間板変性疾患治療市場、従来型医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ステロイド性抗炎症薬（NSAID）
• オピオイド
• 筋弛緩剤
• コルチコステロイド
• 抗うつ薬
• 世界の椎間板変性疾患治療市場、新規治療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子治療
• 幹細胞療法
• 多血小板血漿（PRP）療法
• 生物学的製剤
• 再生医療
• 細胞ベースの治療法
• 成長因子療法

第7章 地域別・国別分析

• 世界の椎間板変性疾患治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の椎間板変性疾患治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 椎間板変性疾患治療市場：競合情勢
• 椎間板変性疾患治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline PLC
• Medtronic plc
• Amgen Inc.
• Baxter International Inc.
• B. Braun SE
• Zimmer Biomet Holdings Inc.
• Arthrex Inc.
• Ferring B.V.
• Biocon Limited
• Integra LifeSciences Holdings Corporation
• NuVasive Inc.
• Globus Medical Inc.
• Orthofix Medical Inc.
• RTI Surgical Holdings Inc.
• LifeNet Health

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 椎間板変性疾患治療市場2029：新たな機会を提供する国
• 椎間板変性疾患治療市場2029：新たな機会を提供するセグメント
• 椎間板変性疾患治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Degenerative disc disease treatment encompasses various medical approaches designed to alleviate symptoms and enhance functionality in individuals with degenerative disc disease, a condition where the spinal discs lose their cushioning ability over time. Treatments may include physical therapy, pain management with medications, lifestyle changes, and, in some cases, surgical procedures like discectomy or spinal fusion to relieve nerve pressure and stabilize the spine.

The primary types of treatment for degenerative disc disease are conventional drugs and novel therapies. Conventional drugs involve standard medications used to manage symptoms, such as pain relievers and anti-inflammatory drugs. These medications can be administered orally or via injection and are utilized in various settings, including hospitals, ambulatory surgical centers, and orthopedic centers.

The degenerative disc disease treatment market research report is one of a series of new reports from The Business Research Company that provides degenerative disc disease treatment market statistics, including degenerative disc disease treatment industry global market size, regional shares, competitors with a degenerative disc disease treatment market share, detailed degenerative disc disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the degenerative disc disease treatment industry. This degenerative disc disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The degenerative disc disease treatment market size has grown strongly in recent years. It will grow from $27.07 billion in 2024 to $29.01 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to an aging population, a sedentary lifestyle, advances in medical technology, increased awareness, rising obesity rates, growing sports injuries, and healthcare access expansion.

The degenerative disc disease treatment market size is expected to see strong growth in the next few years. It will grow to $37.86 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to rising healthcare expenditure, growing demand for minimally invasive procedures, enhanced patient education, expanding clinical research, and rising global incidence of spine disorders. Major trends in the forecast period include integration of AI and machine learning, the development of regenerative medicine, advancements in minimally invasive surgery, wearable technology, 3D printing for custom implants, telemedicine, and remote consultations, and a focus on personalized medicine.

The increasing incidence of sports injuries is expected to drive the growth of the degenerative disc disease treatment market in the coming years. Sports injuries refer to physical damage or trauma sustained by athletes or individuals involved in physical activities, often caused by sudden impacts, overuse, or improper techniques. The rise in sports injuries is often linked to factors such as higher participation rates, more rigorous training routines, and a stronger focus on competitive performance. Degenerative disc disease treatment is utilized to manage chronic spinal pain and restore function when disc degeneration affects athletes' performance and mobility. For example, in November 2023, Howden Group Holdings Ltd, a UK-based insurance intermediary company, reported that injuries in October 2022 led to players being sidelined for an average of 11.35 days before tournaments, with this number increasing to 19.41 days by January 2023. Therefore, the growing number of sports injuries is fueling the expansion of the degenerative disc disease treatment market.

Leading companies in the degenerative disc disease treatment market are focusing on developing innovative therapies, such as injectable disc cell therapy (IDCT), to enhance patient outcomes by increasing disc volume, relieving low back pain, and reducing reliance on pain medications. Injectable disc cell therapy (IDCT) is a regenerative treatment designed for symptomatic lumbar degenerative disc disease. For instance, in February 2023, DiscGenics Inc., a US-based biopharmaceutical company, received FDA regenerative medicine advanced therapy designation for its injectable disc cell therapy (IDCT), which targets symptomatic lumbar degenerative disc disease. This cutting-edge therapy employs a live progenitor cell population derived from donated adult human intervertebral disc tissue. IDCT aims to boost disc volume, alleviate low back pain, and lessen the need for pain medication in affected patients.

In January 2023, Companion Spine LLC, a US-based spine care company, acquired Backbone SAS for an undisclosed amount. This acquisition is intended to enhance Companion's portfolio of medical implants for treating spine and back pain. Backbone SAS, based in France, specializes in developing and manufacturing medical devices for spine and back pain treatment.

Major companies operating in the degenerative disc disease treatment market are Pfizer Inc., Johnson And Johnson, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Medtronic plc, Amgen Inc., Baxter International Inc., B. Braun SE, Zimmer Biomet Holdings Inc., Arthrex Inc., Ferring B.V., Biocon Limited, Integra LifeSciences Holdings Corporation, NuVasive Inc., Globus Medical Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., LifeNet Health

North America was the largest region in the degenerative disc disease treatment market in 2024. The regions covered in the degenerative disc disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the degenerative disc disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The degenerative disc disease treatment market consists of revenues earned by entities by providing services such as medical consultations, surgical procedures, and post-treatment rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The degenerative disc disease treatment market also includes sales of spinal implants, orthopedic braces, pain relief medications, physical therapy equipment, and diagnostic imaging tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Degenerative Disc Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on degenerative disc disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for degenerative disc disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The degenerative disc disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Conventional Drugs; Novel Therapies
• 2) By Route Of Administration: Oral; Injectable
• 3) By End User: Hospitals; Ambulatory Surgical Centers; Orthopedic Center
• Subsegments:
• 1) By Conventional Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Opioids; Muscle Relaxants; Corticosteroids; Antidepressants
• 2) By Novel Therapies: Gene Therapy; Stem Cell Therapy; Platelet-Rich Plasma (PRP) Therapy; Biologic Agents; Regenerative Medicine; Cell-Based Therapies; Growth Factor Therapies
• Companies Mentioned: Pfizer Inc.; Johnson And Johnson; Sanofi S.A.; AstraZeneca Plc; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Degenerative Disc Disease Treatment Market Characteristics

3. Degenerative Disc Disease Treatment Market Trends And Strategies

4. Degenerative Disc Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Degenerative Disc Disease Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Degenerative Disc Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Degenerative Disc Disease Treatment Market Growth Rate Analysis
• 5.4. Global Degenerative Disc Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Degenerative Disc Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Degenerative Disc Disease Treatment Total Addressable Market (TAM)

6. Degenerative Disc Disease Treatment Market Segmentation

• 6.1. Global Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional Drugs
• Novel Therapies
• 6.2. Global Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• 6.3. Global Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Center
• 6.4. Global Degenerative Disc Disease Treatment Market, Sub-Segmentation Of Conventional Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Opioids
• Muscle Relaxants
• Corticosteroids
• Antidepressants
• 6.5. Global Degenerative Disc Disease Treatment Market, Sub-Segmentation Of Novel Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Stem Cell Therapy
• Platelet-Rich Plasma (PRP) Therapy
• Biologic Agents
• Regenerative Medicine
• Cell-Based Therapies
• Growth Factor Therapies

7. Degenerative Disc Disease Treatment Market Regional And Country Analysis

• 7.1. Global Degenerative Disc Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Degenerative Disc Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Degenerative Disc Disease Treatment Market

• 8.1. Asia-Pacific Degenerative Disc Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Degenerative Disc Disease Treatment Market

• 9.1. China Degenerative Disc Disease Treatment Market Overview
• 9.2. China Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Degenerative Disc Disease Treatment Market

• 10.1. India Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Degenerative Disc Disease Treatment Market

• 11.1. Japan Degenerative Disc Disease Treatment Market Overview
• 11.2. Japan Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Degenerative Disc Disease Treatment Market

• 12.1. Australia Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Degenerative Disc Disease Treatment Market

• 13.1. Indonesia Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Degenerative Disc Disease Treatment Market

• 14.1. South Korea Degenerative Disc Disease Treatment Market Overview
• 14.2. South Korea Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Degenerative Disc Disease Treatment Market

• 15.1. Western Europe Degenerative Disc Disease Treatment Market Overview
• 15.2. Western Europe Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Degenerative Disc Disease Treatment Market

• 16.1. UK Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Degenerative Disc Disease Treatment Market

• 17.1. Germany Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Degenerative Disc Disease Treatment Market

• 18.1. France Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Degenerative Disc Disease Treatment Market

• 19.1. Italy Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Degenerative Disc Disease Treatment Market

• 20.1. Spain Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Degenerative Disc Disease Treatment Market

• 21.1. Eastern Europe Degenerative Disc Disease Treatment Market Overview
• 21.2. Eastern Europe Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Degenerative Disc Disease Treatment Market

• 22.1. Russia Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Degenerative Disc Disease Treatment Market

• 23.1. North America Degenerative Disc Disease Treatment Market Overview
• 23.2. North America Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Degenerative Disc Disease Treatment Market

• 24.1. USA Degenerative Disc Disease Treatment Market Overview
• 24.2. USA Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Degenerative Disc Disease Treatment Market

• 25.1. Canada Degenerative Disc Disease Treatment Market Overview
• 25.2. Canada Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Degenerative Disc Disease Treatment Market

• 26.1. South America Degenerative Disc Disease Treatment Market Overview
• 26.2. South America Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Degenerative Disc Disease Treatment Market

• 27.1. Brazil Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Degenerative Disc Disease Treatment Market

• 28.1. Middle East Degenerative Disc Disease Treatment Market Overview
• 28.2. Middle East Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Degenerative Disc Disease Treatment Market

• 29.1. Africa Degenerative Disc Disease Treatment Market Overview
• 29.2. Africa Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Degenerative Disc Disease Treatment Market Competitive Landscape And Company Profiles

• 30.1. Degenerative Disc Disease Treatment Market Competitive Landscape
• 30.2. Degenerative Disc Disease Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Degenerative Disc Disease Treatment Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline PLC
• 31.2. Medtronic plc
• 31.3. Amgen Inc.
• 31.4. Baxter International Inc.
• 31.5. B. Braun SE
• 31.6. Zimmer Biomet Holdings Inc.
• 31.7. Arthrex Inc.
• 31.8. Ferring B.V.
• 31.9. Biocon Limited
• 31.10. Integra LifeSciences Holdings Corporation
• 31.11. NuVasive Inc.
• 31.12. Globus Medical Inc.
• 31.13. Orthofix Medical Inc.
• 31.14. RTI Surgical Holdings Inc.
• 31.15. LifeNet Health

32. Global Degenerative Disc Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Degenerative Disc Disease Treatment Market

34. Recent Developments In The Degenerative Disc Disease Treatment Market

35. Degenerative Disc Disease Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Degenerative Disc Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Degenerative Disc Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Degenerative Disc Disease Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer